Back to User profile » Dr Yuntao Jia
Paper published by Dr Yuntao Jia:
Original Research
Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma
Li J, Jia Y, Shao C, Li Y, Song J
Therapeutics and Clinical Risk Management 2023, 19:329-339
Published Date: 5 April 2023